T2 Biosystems, Inc. (NASDAQ:TTOO) Short Interest Update

T2 Biosystems, Inc. (NASDAQ:TTOO) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totalling 826,900 shares, a drop of 12.3% from the December 31st total of 942,500 shares. Approximately 6.6% of the company’s stock are short sold. Based on an average daily trading volume, of 1,080,000 shares, the short-interest ratio is presently 0.8 days.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on T2 Biosystems in a report on Wednesday, January 29th. They set a “sell” rating on the stock.

T2 Biosystems Price Performance

Shares of T2 Biosystems stock opened at $0.22 on Monday. T2 Biosystems has a 12 month low of $0.21 and a 12 month high of $6.95. The business has a fifty day simple moving average of $0.38 and a two-hundred day simple moving average of $1.75.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.